Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Lung Neoplasms 5 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Hot Flashes 2 Glioblastoma 2 Carcinoma, Non-Small-Cell Lung 2 COVID-19 2 Brain Neoplasms 2 Water-Electrolyte Imbalance 1 Ventilator-Induced Lung Injury 1 Surgical Wound 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Severe Acute Respiratory Syndrome 1 Rectal Neoplasms 1 Postoperative Complications 1 Pathologic Complete Response 1 Neoplasm, Residual 1 Mastocytosis 1 Lymphopenia 1 Lymphoma, Non-Hodgkin 1 Lymphedema 1 Lower Urinary Tract Symptoms 1 Locally Advanced Head and Neck Squamous Cell Carcinoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Hairy Cell 1 Hypersensitivity 1

Interventions

Interleukin-7 2 angiotensin I (1-7) 1 Thymalfasin 1 Sodium Chloride 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphopenia × Sodium Chloride × Clear all

NCT04426201 2024-04-11

ILIAD-7-US-O

Revimmune

Phase 2 Terminated

COVID-19, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡